Synch acted as legal advisor to AlzeCure Pharma. The board of directors for AlzeCure Pharma has resolved a rights issue of approximately SEK 53 million. In...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here